 Shares of NanoViricides Inc NYSE: NNVC, a developer of antiviral therapies based on a novel nanomedicines technology, are higher Monday. What Happened: NanoViricides said its pan-Coronavirus COVID-19 drug candidate, NV-CoV-2, was found to be effective against SARS-CoV-2 in a standard cell culture pseudovirion assay. 